Objective <p>To assess the utility of clinical and MRI features in distinguishing ovarian clear cell carcinoma (CCC) from adnexal masses with ovarian-adnexal reporting and data system (O-RADS) MRI scores of 4–5.</p> Methods <p>This retrospective study included 850 patients with indeterminate adnexal masses on ultrasound. Two radiologists evaluated all preoperative MRIs using the O-RADS MRI risk stratification system. Patients with O-RADS MRI scores of 4–5 were divided into a training set (<i>n</i> = 135, hospital A) and a test set (<i>n</i> = 86, hospital B). Clinical and MRI features were compared between CCC and non-CCC patients. Analysis of variance and support vector machine were used to develop four CCC prediction models. Tenfold cross-validation was applied to determine the hyperparameters. Model performance was evaluated by the area under the curve (AUC) and decision curve.</p> Results <p>221 patients were included (30 CCCs, 191 non-CCCs). CA125, HE4, CEA, ROMA, endometriosis, shape, parity, unilocular, component, the growth pattern of mural nodules, high signal on T1WI, number of nodules, the ratio of signal intensity, and the ADC value were significantly different between CCCs and non-CCCs. The kappa and interobserver correlation coefficient of each MRI feature exceeded 0.85. The comprehensive model combining clinical and MRI features had a greater AUC than the clinical model and tumour maker model (0.92 vs 0.66 and 0.78 in the test set; both <i>p</i> &lt; 0.05), displaying improved net benefit.</p> Conclusions <p>The comprehensive model combining clinical and MRI features can effectively differentiate CCC from adnexal masses with O-RADS MRI scores of 4–5.</p> Critical relevance statement <p>CCC has a high incidence rate in Asians and has limited sensitivity to platinum chemotherapy. This comprehensive model improves CCC prediction ability and clinical applicability for facilitating individualised clinical decision-making.</p> Key Points <p><UnorderedList Mark="Bullet"> <ItemContent> <p>Identifying ovarian CCC preoperatively is beneficial for treatment planning.</p> </ItemContent> <ItemContent> <p>Ovarian CCC tends to be high-signal on T1WI, unilocular, big size, with endometriosis and low CEA.</p> </ItemContent> <ItemContent> <p>This model, integrating clinical and MRI features, can differentiate ovarian CCC from adnexal masses with O-RADS MRI scores 4–5.</p> </ItemContent> </UnorderedList></p> Graphical Abstract <p></p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

The value of MRI in differentiating ovarian clear cell carcinoma from other adnexal masses with O-RADS MRI scores of 4–5

  • Lingling Lin,
  • Le Fu,
  • Huawei Wu,
  • Saiming Cheng,
  • Guangquan Chen,
  • Lei Chen,
  • Jun Zhu,
  • Yu Wang,
  • Jiejun Cheng

摘要

Objective

To assess the utility of clinical and MRI features in distinguishing ovarian clear cell carcinoma (CCC) from adnexal masses with ovarian-adnexal reporting and data system (O-RADS) MRI scores of 4–5.

Methods

This retrospective study included 850 patients with indeterminate adnexal masses on ultrasound. Two radiologists evaluated all preoperative MRIs using the O-RADS MRI risk stratification system. Patients with O-RADS MRI scores of 4–5 were divided into a training set (n = 135, hospital A) and a test set (n = 86, hospital B). Clinical and MRI features were compared between CCC and non-CCC patients. Analysis of variance and support vector machine were used to develop four CCC prediction models. Tenfold cross-validation was applied to determine the hyperparameters. Model performance was evaluated by the area under the curve (AUC) and decision curve.

Results

221 patients were included (30 CCCs, 191 non-CCCs). CA125, HE4, CEA, ROMA, endometriosis, shape, parity, unilocular, component, the growth pattern of mural nodules, high signal on T1WI, number of nodules, the ratio of signal intensity, and the ADC value were significantly different between CCCs and non-CCCs. The kappa and interobserver correlation coefficient of each MRI feature exceeded 0.85. The comprehensive model combining clinical and MRI features had a greater AUC than the clinical model and tumour maker model (0.92 vs 0.66 and 0.78 in the test set; both p < 0.05), displaying improved net benefit.

Conclusions

The comprehensive model combining clinical and MRI features can effectively differentiate CCC from adnexal masses with O-RADS MRI scores of 4–5.

Critical relevance statement

CCC has a high incidence rate in Asians and has limited sensitivity to platinum chemotherapy. This comprehensive model improves CCC prediction ability and clinical applicability for facilitating individualised clinical decision-making.

Key Points

Identifying ovarian CCC preoperatively is beneficial for treatment planning.

Ovarian CCC tends to be high-signal on T1WI, unilocular, big size, with endometriosis and low CEA.

This model, integrating clinical and MRI features, can differentiate ovarian CCC from adnexal masses with O-RADS MRI scores 4–5.

Graphical Abstract